Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 413 clinical trials
Featured trial
NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

NAC-MD-01 Hypertension study for patients with stage 1 or stage 2 essential hypertension

  • 552 views
  • 25 Mar, 2021
  • 1 location
Featured trial
Could you have thinning bones or osteoporosis?

Could you have thinning bones or osteoporosis?

  • 596 views
  • 25 Mar, 2021
  • 1 location
Non-inferiority of Lower Dose Calcium Supplementation During Pregnancy

The World Health Organization currently recommends that pregnant women in populations with low calcium intake receive daily calcium supplementation (1500 - 2000 mg) divided into three doses

Accepts healthy volunteers
  • 42 views
  • 01 Feb, 2022
  • 3 locations
Effectiveness of a Proactive Cardiovascular Primary Prevention Strategy, With or Without the Use of Coronary Calcium Screening, in Preventing Future Major Adverse Cardiac Events (CorCal)

The primary objective of this study is to test the effectiveness of a proactive cardiovascular primary prevention strategy, with or without the use of coronary calcium screening, compared to

Accepts healthy volunteers
  • 0 views
  • 26 Feb, 2022
  • 1 location
Efficacy in Alveolar Bone Regeneration With Autologous MSCs and Biomaterial in Comparison to Autologous Bone Grafting (Maxibone)

A randomized controlled clinical multi center trial to assess the efficacy of a combination of autologous mesenchymal stem cells and biomaterial in jaw bone regeneration prior to dental implant placement in comparison to standard autologous bone block grafting.

bone graft
Accepts healthy volunteers
dental implantation
  • 126 views
  • 28 Feb, 2022
  • 4 locations
Efficacy and Safety of LY01011 and Xgeva in Patients With Bone Metastases From Solid Tumors

This is a multicenterrandomized, double-blind, active-controlled, parallel-group study comparing efficacy and safety of LY01011 (recombinant anti-RANKL human monoclonal antibody injection) and Xgeva in patients with bone metastases from solid tumors.

  • 12 views
  • 16 Jun, 2021
  • 1 location
Twice Against Thrice-weekly Hemodialysis (TATH)

Hemodialysis is the most worldwide prescribed renal replacement therapy for patients with end-stage renal disease. The frequency of sessions per week remains a debatable issue. In the majority of developed Western and Asian countries, patients on chronic hemodialysis are undergoing three dialysis sessions weekly. In developing countries and some developed …

chronic renal failure
hypertension
chronic hemodialysis
renal replacement therapy
  • 124 views
  • 26 Feb, 2022
  • 1 location
Effects of Statin for Elderly Patients With Atherosclerotic Cardiovascular Disease

High-dose statins can reduce mortality and cardiovascular events in patients with established atherosclerotic cardiovascular disease (ASCVD). Therefore, US and European recommendations recommend that established ASCVD patients (coronary artery disease, cerebrovascular disease, peripheral vascular disease) use high-dose statins to lower LDL cholesterol levels by at least 50%. However, in actual practice, …

LDL Cholesterol
ezetimibe
cardiovascular disease
rosuvastatin
hmg-coa reductase inhibitors
  • 0 views
  • 12 Dec, 2021
  • 2 locations
A Study to Compare Efficacy, Pharmacokinetics, Pharmacodynamics, Safety and Immunogenicity of MB09 [Proposed Denosumab Biosimilar] to Prolia® [EU-sourced] in Postmenopausal Osteoporosis (SIMBA Study)

This is a randomized, double-blind, parallel, multicenter, multinational study to compare the efficacy, pharmacokinetics, pharmacodynamics, safety and immunogenicity of MB09 versus Prolia® in postmenopausal women with osteoporosis

  • 0 views
  • 29 Apr, 2022
  • 10 locations
Outcome Research to Confirm the Anti-anginal Effect of T89 in Patients With Stable Angina

This is a multi-center, double-blind, randomized, placebo-controlled, parallel-group phase 3 clinical study to confirm the safety and efficacy of T89 in patients with stable angina pectoris, with an extended open-label period to evaluate the long-term safety of T89. This study includes three main periods: the first study period is a …

  • 0 views
  • 04 Mar, 2022
  • 1 location